Skip to main content
SAMJIN PHARMACEUTICAL CO.,LTD logo

SAMJIN PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 005500 ISIN · KR7005500004 KO Manufacturing
Open in API
Filings indexed 253 across all filing types
Latest filing 2023-12-06 Major Shareholding Noti…
Country KR South Korea
Listing KO 005500

About SAMJIN PHARMACEUTICAL CO.,LTD

https://www.samjinpharm.co.kr/

Samjin Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's portfolio includes a wide range of over-the-counter (OTC) and prescription drugs, offered in various formulations such as oral, drop, and injectable forms. Notable products include the analgesic Gevorin, the antiplatelet agent Plavix, and the hypercholesterolemia treatment Newstatin-R. A central part of its strategy is a strong commitment to R&D, focusing on creating innovative new drugs to address diseases with high unmet medical needs. The company actively develops novel therapeutics for severe conditions, including cardiovascular, respiratory, and gastrointestinal diseases, with the goal of becoming a global pharmaceutical innovator.

Recent filings

Filing Released Lang Actions
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a regulatory filing in South Korea (DART system). It details changes in share ownership by a major shareholder (Hana Pharm Co., Ltd.) in Samjin Pharm Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks changes in significant share ownership levels and insider/major shareholder holdings.
2023-12-06 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a regulatory filing in South Korea (DART system) used to disclose insider trading or changes in major shareholdings. This specific document is a correction (정정신고) of a previously filed report regarding share acquisitions by Hana Pharm Co., Ltd. in Samjin Pharm Co., Ltd. Since it details transactions in own shares or shares of another company by a major shareholder/insider, it falls under the category of 'Director's Dealing' (DIRS) or 'Major Shareholding Notification' (MRQ). Given the focus on the reporting of specific share ownership changes by a major shareholder, 'Major Shareholding Notification' (MRQ) is the most accurate classification.
2023-12-06 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose changes in shareholdings by major shareholders or insiders. This falls under the category of 'Major Shareholding Notification' (MRQ) as it details the acquisition of shares by a major shareholder (Hana Pharm Co., Ltd.) in the issuing company (Samjin Pharm Co., Ltd.).
2023-12-06 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a regulatory filing in South Korea (DART system) used to disclose changes in shareholdings by insiders or major shareholders. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions by major shareholders/executives, or more broadly, it is a regulatory disclosure of ownership changes.
2023-12-06 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a regulatory filing in South Korea (DART system) detailing changes in shareholdings by major shareholders or insiders. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal or entity-level share transactions by major stakeholders.
2023-12-06 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a regulatory filing in South Korea (DART system) used to disclose changes in shareholdings by insiders or major shareholders. This falls under the category of 'Director's Dealing' (DIRS) as it details personal/entity share transactions by a major shareholder (Hana Pharm Co., Ltd.) in the issuing company (Samjin Pharm Co., Ltd.).
2023-12-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.